ClinicalTrials.Veeva

Menu

Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

B

Bispebjerg Hospital

Status

Completed

Conditions

Duodenal Cancer

Treatments

Procedure: Pancreaduodenectomy and possible adjuvant therapy

Study type

Observational

Funder types

Other

Identifiers

NCT05134961
Duodenal adenocarcinoma

Details and patient eligibility

About

The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.

Enrollment

113 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients subjected to resection of primary duodenal adenocarcinoma

Exclusion criteria

  • None.

Trial design

113 participants in 1 patient group

Patients undergoing resection of primary duodenal cancer
Description:
Tumors comprised histologically confirmed adenocarcinomas in the duodenum excluding adenocarcinoma of the ampulla of Vater and adenocarcinomas with gastric and pancreato-biliary morphology and immunohistochemistry.
Treatment:
Procedure: Pancreaduodenectomy and possible adjuvant therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems